Xoma Corp file registration statement Securities Exchange Commission cover propose offering 1.3 mln common shares. Xoma biotechnology company produce monoclonal antibody-based product treat form cancer proceeds fund research product development human clinical trial expansion manufacturing capacity work capital. It Dillon Read Co Inc Alex Brown Sons Inc manage underwriting. Reuter 